Twitter-Elon Buy & Edit Button Rollout; Pixel 7 Leak; Android Dynamic Island; Walmart & CVS-Trial Over Homeopathic PlacementPosted: October 4, 2022
Twitter trading was halted halted over report that Elon Musk will go ahead with bid to buy company at $54.20 a share. Meanwhile, Twitter is rolling out the coveted edit button to edit Tweets. According to TechCrunch.com, right now it is only being released to Twitter Blue subscribers in Canada, Australia, and New Zealand, but Twitter says US Twitter Blue users will get it ‘soon.’ With the edit button, you will be able to edit a Tweet any time within 30 minutes of sending it…and can edit it up to 5 times in that 30 minute period. Edited Tweets will show a time stamp indicating when the Tweet was edited. Also, as you scroll through your feed, edited Tweets will display a little pencil icon next to them to indicate that the Tweet has been modified.
The Pixel 7 and 7 Pro, as well as the Pixel Watch will be rolled out officially on the 6th…just a couple days from now. Of course, there is a nice, big leak! Mashable.com reports that the Pixel 7 has a 6.3 inch display and a 90 Hertz refresh rate…the latter not even an upgrade from the 6. The rear cams are also unchanged. The Pixel 7 pro has a humongous 6.7 inch screen with adaptive 120 Hertz refresh rate…that’s the same as last Year’s Pixel 6 Pro, but also the same as the new iPhone 14 Plus and Pro Max. One leak has face unlock and another doesn’t…so on that point, we’ll have to wait a couple days to see which is right.
If you have an Android phone and you’re having the sads because your phone doesn’t have a ‘dynamic island’ like the new iPhone 14s, cheer up! ‘There’s an app for that!’ Androidpolice.com says you can get DynamicSpot…which has already gotten a million downloads at the Google Play store! You will need a relatively recent Android that has a hole-punch cutout. If so, you’re good to go. No more Apple envy…at least for this feature.
A three judge panel on the District of Columbia Circuit Court of Appeal ruled unanimously that CVS and Walmart will have to go to trial over placing homeopathic products right next to legitimate over the counter medicines approved by the FDA. Arstechnica.com says the cases were filed against the firms by the nonprofit Center for Inquiry in 2018 and 2019. CFI may need more evidence to prove their case at trial, but they claimed that deceptive placement of the water-based products violated the District of Columbia Consumer Protection Procedures Act (CPPA).